Search research articles
Contact Us
Filters
Showing results (21-30 of 105) with videos related to
Page
of 11
Sort By:
Leukemia & Lymphoma
|
September 20, 2018
Myelofibrosis patients can develop extramedullary complications including renal amyloidosis and sclerosing hematopoietic tumor while otherwise meeting traditional measures of ruxolitinib response
Daria V Babushok, Ernest J Nelson, Jennifer J D Morrissette, et al.
American Journal of Hematology
|
May 26, 2017
Multicenter analysis of the use of transjugular intrahepatic portosystemic shunt for management of MPN-associated portal hypertension
Christopher R Reilly, Daria V Babushok, Karlyn Martin, et al.
Blood
|
November 7, 2007
Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders
Elizabeth O Hexner, Cynthia Serdikoff, Mahfuza Jan, et al.
American Journal of Hematology
|
May 4, 2013
Receipt of maintenance therapy is most predictive of survival in older acute lymphoblastic leukemia patients treated with intensive induction chemotherapy regimens
Daniel J Landsburg, Edward Stadtmauer, Alison Loren, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 25, 2007
Umbilical cord blood xenografts in immunodeficient mice reveal that T cells enhance hematopoietic engraftment beyond overcoming immune barriers by stimulating stem cell differentiation
Elizabeth O Hexner, Gwenn-Aël H Danet-Desnoyers, Yi Zhang, et al.
Leukemia
|
October 13, 2025
Defining remission following hematopoietic cell transplant for myelofibrosis: an international expert panel consensus
Rachel B Salit, Elizabeth O Hexner, Nico Gagelmann, et al.
American Journal of Hematology
|
May 21, 2016
Unrelated donors are associated with improved relapse-free survival compared to related donors in patients with myelodysplastic syndrome undergoing reduced intensity allogeneic stem cell transplantation
Clinton Yam, Lisa Crisalli, Selina M Luger, et al.
Leukemia & Lymphoma
|
January 24, 2024
Characterization of the calcineurin inhibitor pain syndrome in patients undergoing allogeneic hematopoietic cell transplantation
Craig W Freyer, Alison Carulli, Noelle V Frey, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 28, 2014
Acute cholecystitis is a common complication after allogeneic stem cell transplantation and is associated with the use of total parenteral nutrition
Stephen J Bagley, Alison R Sehgal, Saar Gill, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 7, 2018
Higher Donor Apheresis Blood Volumes Are Associated with Reduced Relapse Risk and Improved Survival in Reduced-Intensity Allogeneic Transplantations with Unrelated Donors
Lisa M Crisalli, Joanne T Hinkle, Christopher C Walling, et al.
Page
of 11
Search research articles
Search
Showing results (21-30 of 105) with videos related to
Sort By:
Page
of 11
Leukemia & Lymphoma
|
September 20, 2018
Myelofibrosis patients can develop extramedullary complications including renal amyloidosis and sclerosing hematopoietic tumor while otherwise meeting traditional measures of ruxolitinib response
Daria V Babushok, Ernest J Nelson, Jennifer J D Morrissette, et al.
American Journal of Hematology
|
May 26, 2017
Multicenter analysis of the use of transjugular intrahepatic portosystemic shunt for management of MPN-associated portal hypertension
Christopher R Reilly, Daria V Babushok, Karlyn Martin, et al.
Blood
|
November 7, 2007
Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders
Elizabeth O Hexner, Cynthia Serdikoff, Mahfuza Jan, et al.
American Journal of Hematology
|
May 4, 2013
Receipt of maintenance therapy is most predictive of survival in older acute lymphoblastic leukemia patients treated with intensive induction chemotherapy regimens
Daniel J Landsburg, Edward Stadtmauer, Alison Loren, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 25, 2007
Umbilical cord blood xenografts in immunodeficient mice reveal that T cells enhance hematopoietic engraftment beyond overcoming immune barriers by stimulating stem cell differentiation
Elizabeth O Hexner, Gwenn-Aël H Danet-Desnoyers, Yi Zhang, et al.
Leukemia
|
October 13, 2025
Defining remission following hematopoietic cell transplant for myelofibrosis: an international expert panel consensus
Rachel B Salit, Elizabeth O Hexner, Nico Gagelmann, et al.
American Journal of Hematology
|
May 21, 2016
Unrelated donors are associated with improved relapse-free survival compared to related donors in patients with myelodysplastic syndrome undergoing reduced intensity allogeneic stem cell transplantation
Clinton Yam, Lisa Crisalli, Selina M Luger, et al.
Leukemia & Lymphoma
|
January 24, 2024
Characterization of the calcineurin inhibitor pain syndrome in patients undergoing allogeneic hematopoietic cell transplantation
Craig W Freyer, Alison Carulli, Noelle V Frey, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 28, 2014
Acute cholecystitis is a common complication after allogeneic stem cell transplantation and is associated with the use of total parenteral nutrition
Stephen J Bagley, Alison R Sehgal, Saar Gill, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 7, 2018
Higher Donor Apheresis Blood Volumes Are Associated with Reduced Relapse Risk and Improved Survival in Reduced-Intensity Allogeneic Transplantations with Unrelated Donors
Lisa M Crisalli, Joanne T Hinkle, Christopher C Walling, et al.
Page
of 11